CVS HEALTH Corp: Form 10-Q for the period ended Jun 30, 2015
Filed with the SEC on Aug 4, 2015 and accepted by EDGAR at Aug 4, 2015, 16:54 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-04-01 to 2015-06-30 | $37.17bn | us-gaap:Revenues |
| Revenue | 6 months2015-01-01 to 2015-06-30 | $73.50bn | us-gaap:Revenues |
| Cost of revenue | 3 months2015-04-01 to 2015-06-30 | $30.77bn | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2015-01-01 to 2015-06-30 | $60.94bn | us-gaap:CostOfRevenue |
| Gross profit | 3 months2015-04-01 to 2015-06-30 | $6.40bn | us-gaap:GrossProfit |
| Gross profit | 6 months2015-01-01 to 2015-06-30 | $12.57bn | us-gaap:GrossProfit |
| Operating income | 3 months2015-04-01 to 2015-06-30 | $2.26bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2015-01-01 to 2015-06-30 | $4.39bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-04-01 to 2015-06-30 | $171.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2015-01-01 to 2015-06-30 | $309.0m | us-gaap:InterestExpense |
| Income tax | 3 months2015-04-01 to 2015-06-30 | $824.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2015-01-01 to 2015-06-30 | $1.60bn | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 6 months2015-01-01 to 2015-06-30 | $2.49bn | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2015-04-01 to 2015-06-30 | $1.12 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2015-01-01 to 2015-06-30 | $2.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2015-04-01 to 2015-06-30 | $1.13 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2015-01-01 to 2015-06-30 | $2.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2015-04-01 to 2015-06-30 | 1,132,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2015-01-01 to 2015-06-30 | 1,134,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2015-01-01 to 2015-06-30 | $3.02bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2015-01-01 to 2015-06-30 | $942.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2015-01-01 to 2015-06-30 | $794.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2015-01-01 to 2015-06-30 | $2.93bn | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2015-06-30 | $1.24bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-06-30 | $26.40bn | us-gaap:AssetsCurrent |
| Total assets | At period end2015-06-30 | $74.67bn | us-gaap:Assets |
| Current liabilities | At period end2015-06-30 | $20.39bn | us-gaap:LiabilitiesCurrent |
| Short-term borrowings | At period end2015-06-30 | $1.49bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2015-06-30 | $37.13bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000064803-15-000054. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.